Manufacturers Life Insurance Company, The Fate Therapeutics Inc Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 38,464 shares of FATE stock, worth $85,390. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,464
Previous 39,715 3.15%
Holding current value
$85,390
Previous $130,000 3.08%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$3.12 - $5.57 $3,903 - $6,968
-1,251 Reduced 3.15%
38,464 $134,000
Q2 2024

Aug 14, 2024
SELL
$3.26 - $7.08 $65,607 - $142,485
-20,125 Reduced 33.63%
39,715 $130,000
Q1 2024

May 14, 2024
BUY
$3.54 - $8.35 $88,294 - $208,265
24,942 Added 71.47%
59,840 $439,000
Q4 2023

Feb 13, 2024
SELL
$1.65 - $3.94 $108,533 - $259,165
-65,778 Reduced 65.34%
34,898 $130,000
Q3 2023

Nov 15, 2023
BUY
$2.02 - $5.04 $284 - $710
141 Added 0.14%
100,676 $213,000
Q2 2023

Aug 11, 2023
BUY
$4.76 - $6.59 $5,469 - $7,571
1,149 Added 1.16%
100,535 $478,000
Q1 2023

May 15, 2023
SELL
$4.24 - $11.12 $4,634 - $12,154
-1,093 Reduced 1.1%
98,293 $560,000
Q4 2022

Aug 11, 2023
BUY
$9.86 - $23.83 $4,801 - $11,605
487 Added 0.49%
99,386 $1 Million
Q4 2022

Feb 13, 2023
BUY
$9.86 - $23.83 $4,801 - $11,605
487 Added 0.49%
99,386 $1 Million
Q3 2022

Aug 11, 2023
BUY
$21.04 - $36.06 $138,548 - $237,455
6,585 Added 7.13%
98,899 $2.22 Million
Q3 2022

Nov 03, 2022
BUY
$21.04 - $36.06 $138,548 - $237,455
6,585 Added 7.13%
98,899 $2.21 Million
Q2 2022

Aug 11, 2023
BUY
$17.78 - $42.39 $3,111 - $7,418
175 Added 0.19%
92,314 $2.29 Million
Q2 2022

Aug 15, 2022
BUY
$17.78 - $42.39 $3,111 - $7,418
175 Added 0.19%
92,314 $2.29 Million
Q1 2022

Aug 11, 2023
SELL
$29.67 - $60.28 $182,589 - $370,963
-6,154 Reduced 6.26%
92,139 $3.57 Million
Q1 2022

May 20, 2022
BUY
$29.67 - $60.28 $1.51 Million - $3.07 Million
50,994 Added 123.94%
92,139 $3.64 Million
Q4 2021

Feb 16, 2022
SELL
$47.84 - $64.34 $16,791 - $22,583
-351 Reduced 0.85%
41,145 $2.44 Million
Q3 2021

Nov 12, 2021
SELL
$59.27 - $95.73 $206,437 - $333,427
-3,483 Reduced 7.74%
41,496 $2.46 Million
Q2 2021

Aug 12, 2021
BUY
$67.25 - $92.52 $153,262 - $210,853
2,279 Added 5.34%
44,979 $3.9 Million
Q1 2021

May 03, 2021
SELL
$72.16 - $117.4 $9,380 - $15,262
-130 Reduced 0.3%
42,700 $3.52 Million
Q4 2020

Feb 12, 2021
BUY
$38.09 - $100.95 $72,637 - $192,511
1,907 Added 4.66%
42,830 $3.9 Million
Q3 2020

Nov 09, 2020
BUY
$30.41 - $40.5 $103,515 - $137,862
3,404 Added 9.07%
40,923 $1.64 Million
Q2 2020

Aug 10, 2020
SELL
$20.21 - $35.23 $28,071 - $48,934
-1,389 Reduced 3.57%
37,519 $1.22 Million
Q1 2020

May 15, 2020
BUY
$17.28 - $31.88 $119,093 - $219,716
6,892 Added 21.53%
38,908 $864,000
Q4 2019

Feb 14, 2020
SELL
$13.39 - $20.73 $14,742 - $22,823
-1,101 Reduced 3.32%
32,016 $627,000
Q3 2019

Nov 12, 2019
SELL
$15.47 - $22.5 $185 - $270
-12 Reduced 0.04%
33,117 $512,000
Q2 2019

Aug 14, 2019
SELL
$15.61 - $20.44 $106,148 - $138,992
-6,800 Reduced 17.03%
33,129 $673,000
Q1 2019

May 13, 2019
BUY
$13.15 - $18.71 $65,316 - $92,932
4,967 Added 14.21%
39,929 $701,000
Q4 2018

Feb 14, 2019
BUY
$11.48 - $16.98 $10,825 - $16,012
943 Added 2.77%
34,962 $449,000
Q3 2018

Nov 14, 2018
SELL
$8.75 - $16.29 $35,883 - $66,805
-4,101 Reduced 10.76%
34,019 $554,000
Q2 2018

Aug 14, 2018
BUY
$9.16 - $13.48 $10,469 - $15,407
1,143 Added 3.09%
38,120 $432,000
Q1 2018

May 15, 2018
BUY
$6.3 - $13.77 $22,932 - $50,122
3,640 Added 10.92%
36,977 $360,000
Q4 2017

Feb 08, 2018
BUY
$3.94 - $6.64 $49,982 - $84,235
12,686 Added 61.43%
33,337 $203,000
Q3 2017

Nov 14, 2017
BUY
$2.6 - $4.31 $53,692 - $89,005
20,651
20,651 $82,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $215M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email